Cohort Study of Pioglitazone and Cancer Incidence in Participants With Diabetes Mellitus.
Status:
Completed
Trial end date:
2015-05-29
Target enrollment:
Participant gender:
Summary
The purpose of this study was to evaluate whether treatment with pioglitazone is associated
with risk of incident cancer at the 10 most common sites in a cohort of participants with
recognized diabetes.